CBD: Clinical Trials

4 trials for CBD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 11Completed 1
Phase 31Completed 1

Follow CBD: new trials by email Literature Review of CBD trials Research Report on CBD

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain
Cybis™ 10:25 THC:CBD oil - Chronic Pain, Neck Pain
Phase 1 / Phase 2CompletedCymra Life Sciences282021-09-202022-07-07
Efficacy of Inhaled Cannabis for Acute Migraine Treatment
THC ~5%, CBD ~12%, THC ~5% and CBD ~12% - Migraine, Cannabis
Phase 2CompletedUniversity of California, San Diego922020-11-202023-02-28
Is Topical CBD Effective in Treating Thumb Joint Arthritis
CBD, Shea Butter - CBD, Hand Osteoarthritis
Phase 2CompletedUniversity of Virginia182020-07-282025-07-03
Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm
Cannabidiol Oral Solution [Epidiolex] - Blepharospasm, Blepharospasm, Benign Essential
Phase 2 / Phase 3CompletedSilkiss Eye Surgery122020-05-202021-11-02

Narrower conditions

Back Pain (1)  ·  Benign essential blepharospasm (1)  ·  Blepharospasm (1)  ·  Chronic Pain (1)  ·  Marijuana Abuse (1)  ·  Migraine Disorders (1)  ·  Neck Pain (1)  ·  Pain (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Eye Diseases (1)  ·  Eyelid Diseases (1)  ·  Headache Disorders (1)  ·  Headache Disorders, Primary (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Substance-Related Disorders (1)

Interventions

Cannabidiol (2)  ·  Dronabinol (1)  ·  THC 5 (1)  ·  nabiximols (1)  ·  salicylhydroxamic acid (1)

Sponsors

Cymra Life Sciences (1)  ·  Silkiss Eye Surgery (1)  ·  University of California, San Diego (1)  ·  University of Virginia (1)

Countries

United States (3)  ·  Australia (1)

Top investigators

Nathaniel M Schuster, MD (1)  ·  Richard Chye (1)

Results publications

PMID 37606606, PMID 41469488